MiR181a protects against angiotensin II-induced osteopontin expression in vascular smooth muscle cells

Atherosclerosis

Volumn 228, Issue 1, 2013, Pages 168-174

  Remus, Ebony Washington ^a   Lyle, Alicia N ^a   Weiss, Daiana ^a   Landàzuri, Natalia ^a   Weber, Martina ^a   Searles, Charles ^a   Taylor, W Robert ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Angiotensin II; MicroRNA; Osteopontin; Translational control

Indexed keywords

ANGIOTENSIN II; COLLAGEN; MICRORNA; MICRORNA 181A; OSTEOPONTIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CELL ADHESION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; RAT; SEQUENCE ANALYSIS; SMOOTH MUSCLE FIBER; TRANSCRIPTION INITIATION; VASCULAR SMOOTH MUSCLE;

ANGIOTENSIN II; ANIMALS; AORTA; CELLS, CULTURED; GENE EXPRESSION; MICRORNAS; MUSCLE, SMOOTH, VASCULAR; OSTEOPONTIN; RATS; RNA, MESSENGER; TRANSCRIPTION, GENETIC; VASOCONSTRICTOR AGENTS;

EID: 84876810629     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.01.037     Document Type: Article

References (33)

1. Tesanovic S., Vinh A., Gaspari T.A., Casley D., Widdop R.E. Vasoprotective and atheroprotective effects of angiotensin (1-7) in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2010, 30:1606-1613.
2. Mehta P.K., Griendling K.K. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 2007, 292:C82-C97.
3. Weiss D., Sorescu D., Taylor W.R. Angiotensin II and atherosclerosis. Am J Cardiol 2001, 87:25C-32C.
4. Faries P.L., Rohan D.I., Wyers M.C., et al. Vascular smooth muscle cells derived from atherosclerotic human arteries exhibit greater adhesion, migration, and proliferation than venous cells. J Surg Res 2002, 104:22-28.
5. Hansson G.K., Robertson A.K., Soderberg-Naucler C. Inflammation and atherosclerosis. Annu Rev Pathol 2006, 1:297-329.
6. Libby P. Inflammation in atherosclerosis. Nature 2002, 420:868-874.
7. Libby P., Ridker P.M., Maseri A. Inflammation and atherosclerosis. Circulation 2002, 105:1135-1143.
8. Abe K., Nakashima H., Ishida M., et al. Angiotensin II-induced osteopontin expression in vascular smooth muscle cells involves Gq/11, Ras, ERK, Src and Ets-1. Hypertens Res 2008, 31:987-998.
9. Cho H.J., Cho H.J., Kim H.S. Osteopontin: a multifunctional protein at the crossroads of inflammation, atherosclerosis, and vascular calcification. Curr Atheroscler Rep 2009, 11:206-213.
10. Asou Y., Rittling S.R., Yoshitake H., et al. Osteopontin facilitates angiogenesis, accumulation of osteoclasts, and resorption in ectopic bone. Endocrinology 2001, 142:1325-1332.
11. Chakraborty G., Jain S., Behera R., et al. The multifaceted roles of osteopontin in cell signaling, tumor progression and angiogenesis. Curr Mol Med 2006, 6:819-830.
12. Giachelli C.M., Bae N., Almeida M., Denhardt D.T., Alpers C.E., Schwartz S.M. Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. J Clin Invest 1993, 92:1686-1696.
13. Ikeda T., Shirasawa T., Esaki Y., Yoshiki S., Hirokawa K. Osteopontin mRNA is expressed by smooth muscle-derived foam cells in human atherosclerotic lesions of the aorta. J Clin Invest 1993, 92:2814-2820.
14. Bruemmer D., Collins A.R., Noh G., et al. Angiotensin II-accelerated atherosclerosis and aneurysm formation is attenuated in osteopontin-deficient mice. J Clin Invest 2003, 112:1318-1331.
15. Standal T., Borset M., Sundan A. Role of osteopontin in adhesion, migration, cell survival and bone remodeling. Exp Oncol 2004, 26:179-184.
16. Rangaswami H., Bulbule A., Kundu G.C. Osteopontin: role in cell signaling and cancer progression. Trends Cell Biol 2006, 16:79-87.
17. Li J.J., Han M., Wen J.K., Li A.Y. Osteopontin stimulates vascular smooth muscle cell migration by inducing FAK phosphorylation and ILK dephosphorylation. Biochem Biophys Res Commun 2007, 356:13-19.
18. Yue T.L., McKenna P.J., Ohlstein E.H., et al. Osteopontin-stimulated vascular smooth muscle cell migration is mediated by beta 3 integrin. Exp Cell Res 1994, 214:459-464.
19. Weintraub A.S., Schnapp L.M., Lin X., Taubman M.B. Osteopontin deficiency in rat vascular smooth muscle cells is associated with an inability to adhere to collagen and increased apoptosis. Lab Invest 2000, 80:1603-1615.
20. Plasterk R.H. Micro RNAs in animal development. Cell 2006, 124:877-881.
21. Bushati N., Cohen S.M. microRNA functions. Annu Rev Cell Dev Biol 2007, 23:175-205.
22. Griendling K.K., Taubman M.B., Akers M., Mendlowitz M., Alexander R.W. Characterization of phosphatidylinositol-specific phospholipase C from cultured vascular smooth muscle cells. J Biol Chem 1991, 266:15498-15504.
23. Ohmi K., Masuda T., Yamaguchi H., et al. A novel aortic smooth muscle cell line obtained from p53 knock out mice expresses several differentiation characteristics. Biochem Biophys Res Commun 1997, 238:154-158.
24. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
25. Ishida M., Ishida T., Thomas S.M., Berk B.C. Activation of extracellular signal-regulated kinases (ERK1/2) by angiotensin II is dependent on c-Src in vascular smooth muscle cells. Circ Res 1998, 82:7-12.
26. Weintraub A.S., Giachelli C.M., Krauss R.S., Almeida M., Taubman M.B. Autocrine secretion of osteopontin by vascular smooth muscle cells regulates their adhesion to collagen gels. Am J Pathol 1996, 149:259-272.
27. Berk B.C., Haendeler J., Sottile J. Angiotensin II, atherosclerosis, and aortic aneurysms. J Clin Invest 2000, 105:1525-1526.
28. Touyz R.M. Reactive oxygen species and angiotensin II signaling in vascular cells - implications in cardiovascular disease. Braz J Med Biol Res 2004, 37:1263-1273.
29. Bhattacharya SD, Garrison J, Guo H, et al. Micro-RNA-181a regulates osteopontin-dependent metastatic function in hepatocellular cancer cell lines, Surgery, 148, 291-7.
30. van Kouwenhove M., Kedde M., Agami R. MicroRNA regulation by RNA-binding proteins and its implications for cancer. Nat Rev Cancer 2011, 11:644-656.
31. Ma F., Liu X., Li D., et al. MicroRNA-466l upregulates IL-10 expression in TLR-triggered macrophages by antagonizing RNA-binding protein tristetraprolin-mediated IL-10 mRNA degradation. J Immunol 2010, 184:6053-6059.
32. Hein L. Angiotensin II and cell-matrix adhesion: PKCepsilon is essential. Cardiovasc Res 2005, 67:6-8.
33. Zhu N, Zhang D, Chen S, et al. Endothelial enriched microRNAs regulate angiotensin II-induced endothelial inflammation and migration, Atherosclerosis, 215, 286-93.